CN Patent

CN1939290A — 秋水仙碱及它的衍生物的医学用途

Assigned to Individual · Expires 2007-04-04 · 19y expired

What this patent protects

本发明公开了秋水仙碱及它的衍生物的医学用途，采用低浓度的秋水仙碱及它的衍生物显著提高血管内皮细胞释放人体t－PA，从而促进血液纤维蛋白溶解系统活性升高而促进血栓溶解，从而使其能预防、治疗由血管内血栓形成或栓塞而引起的各种疾病。

USPTO Abstract

本发明公开了秋水仙碱及它的衍生物的医学用途，采用低浓度的秋水仙碱及它的衍生物显著提高血管内皮细胞释放人体t－PA，从而促进血液纤维蛋白溶解系统活性升高而促进血栓溶解，从而使其能预防、治疗由血管内血栓形成或栓塞而引起的各种疾病。

Drugs covered by this patent

Patent Metadata

Patent number
CN1939290A
Jurisdiction
CN
Classification
—
Expires
2007-04-04
Drug substance claim
No
Drug product claim
No
Assignee
Individual
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.